These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 12464647)
21. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Daibata M; Speck SH; Mulder C; Sairenji T Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228 [TBL] [Abstract][Full Text] [Related]
22. Tissue specific distribution of Epstein-Barr virus (EBV) BZLF1 gene variants in nasopharyngeal carcinoma (NPC) bearing patients. Sacaze C; Henry S; Icart J; Mariamé B Virus Res; 2001 Dec; 81(1-2):133-42. PubMed ID: 11682132 [TBL] [Abstract][Full Text] [Related]
23. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation. Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047 [TBL] [Abstract][Full Text] [Related]
24. Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV-associated disorders. Schuster V; Ott G; Seidenspinner S; Kreth HW Blood; 1996 Feb; 87(4):1579-85. PubMed ID: 8608250 [TBL] [Abstract][Full Text] [Related]
25. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736 [TBL] [Abstract][Full Text] [Related]
26. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
29. Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Okuno Y; Murata T; Sato Y; Muramatsu H; Ito Y; Watanabe T; Okuno T; Murakami N; Yoshida K; Sawada A; Inoue M; Kawa K; Seto M; Ohshima K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Narita Y; Yoshida M; Goshima F; Kawada JI; Nishida T; Kiyoi H; Kato S; Nakamura S; Morishima S; Yoshikawa T; Fujiwara S; Shimizu N; Isobe Y; Noguchi M; Kikuta A; Iwatsuki K; Takahashi Y; Kojima S; Ogawa S; Kimura H Nat Microbiol; 2019 Mar; 4(3):404-413. PubMed ID: 30664667 [TBL] [Abstract][Full Text] [Related]
30. Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein. Adamson AL; Wright N; LaJeunesse DR Genetics; 2005 Nov; 171(3):1125-35. PubMed ID: 16079238 [TBL] [Abstract][Full Text] [Related]
31. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789 [TBL] [Abstract][Full Text] [Related]
32. Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa. Grunewald V; Bonnet M; Boutin S; Yip T; Louzir H; Levrero M; Seigneurin JM; Raphael M; Touitou R; Martel-Renoir D; Cochet C; Durandy A; Andre P; Lau W; Zeng Y; Joab I Int J Cancer; 1998 Feb; 75(4):497-503. PubMed ID: 9466647 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus: the first human tumor virus and its role in cancer. Pagano JS Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086 [TBL] [Abstract][Full Text] [Related]
34. Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases. Hayes DP; Brink AA; Vervoort MB; Middeldorp JM; Meijer CJ; van den Brule AJ Mol Pathol; 1999 Apr; 52(2):97-103. PubMed ID: 10474689 [TBL] [Abstract][Full Text] [Related]
35. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma. Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297 [TBL] [Abstract][Full Text] [Related]
36. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China. Ji KM; Li CL; Meng G; Han AD; Wu XL Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115 [TBL] [Abstract][Full Text] [Related]
38. Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells. Delecluse S; Poirey R; Zeier M; Schnitzler P; Behrends U; Tsai MH; Delecluse HJ J Virol; 2020 May; 94(10):. PubMed ID: 32102884 [TBL] [Abstract][Full Text] [Related]
39. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583 [TBL] [Abstract][Full Text] [Related]